Pricing Log in Create free account

Redhill Biopharma Ltd. (RDHL) vs Universe Pharmaceuticals INC (UPC)

Redhill Biopharma Ltd. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. Universe Pharmaceuticals INC is the larger, with a market value of $7.0M against $3.8M — 1.9× the size. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −6.42%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Universe Pharmaceuticals INC leads on 7 and Redhill Biopharma Ltd. on 3.

Valuation

Metric RDHL UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.00 n/m 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 8.52 12.22
EV/Sales 6.43 (0.24) 2.87
Earnings yield (142,015.51%) (105.04%) (15.94%)
Free cash flow yield (231,394.02%) 0.00% 0.00%

Profitability

Metric RDHL UPC Drug Manufacturers Specialty & Generic median
Gross margin 35.16% 49.77% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 25.20% (6.42%) (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RDHL UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (61.93%) — 5.22%
EPS growth (last fiscal year) 97.91% 98.71% 42.91%
Revenue growth, 5-year CAGR (66.15%) (10.27%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RDHL UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.17 0.04
Current ratio 0.34 4.05 2.41
Net debt to EBITDA 0.53 10.15 1.01

Dividend

Metric RDHL UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric RDHL UPC Drug Manufacturers Specialty & Generic median
Market cap 3.79m 7.04m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack